CAS 5072-26-4 DL-Buthionine-sulfoximine - Analytical Products / Alfa Chemistry

CAT	AP5072264-B
CAS	5072-26-4
Structure
MDL Number	MFCD00070309
Molecular Weight	222.31
InChI Key	KJQFBVYMGADDTQ-UHFFFAOYSA-N
REAXYS Number	2367136

Description	≥99.0% (TLC)
Solubility	H2O: 50 mg/mL, clear to almost clear, colorless
Assay	≥99.0% (TLC)
Size	250MG, 1G, 5G
Storage Conditions	2-8°C

1

Augmentation of Cisplatin (DDP) Cytotoxicity in Vivo by DL-buthionine Sulfoximine (BSO) in DDP-sensitive And-Resistant Rat Ovarian Tumors and Its Relation to DNA Interstrand Cross Links

G Chen, W J Zeller

Anticancer Res. Nov-Dec 1991;11(6):2231-7.

PMID: 1776864

1

Depletion of Brain Glutathione in Preweanling Mice by L-buthionine Sulfoximine

A Slivka, M B Spina, H I Calvin, G Cohen

J Neurochem. 1988 May;50(5):1391-3.

PMID: 3361302

1

Hepatotoxicity of Eugenol in Mice Depleted of Glutathione by Treatment With DL-buthionine Sulfoximine

T Mizutani, K Satoh, H Nomura, K Nakanishi

Res Commun Chem Pathol Pharmacol. 1991 Feb;71(2):219-30.

PMID: 2047567

1

p-Dichlorobenzene-induced Hepatotoxicity in Mice Depleted of Glutathione by Treatment With Buthionine Sulfoximine

T Mizutani, Y Nakahori, K Yamamoto

Toxicology. Nov-Dec 1994;94(1-3):57-67.

PMID: 7801330

1

Simultaneous Inhibition of Renal Phospholipase A(2) and Glutathione Synthesis by Manoalide and DL-buthionine Sulfoximine Induces Acute Tubular Dysfunction in Rats

A Soejima, S Ishizuka, N Miyake, K Fukuoka, M Suzuki, Y Kamiya, T Nagasawa

Exp Nephrol. Mar-Apr 2000;8(2):84-90.

PMID: 10729747

* Products or Services Interested: DL-Buthionine-sulfoximine (5072-26-4)
* Your question
* Name
* Email
Verification Code